Segall Bryant & Hamill’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-44,698
Closed -$1.49M 577
2017
Q2
$1.49M Sell
44,698
-2,694
-6% -$83.4K 0.04% 332
2017
Q1
$1.52M Buy
47,392
+800
+2% +$27.3K 0.04% 321
2016
Q4
$1.69M Sell
46,592
-465
-1% -$18.6K 0.04% 308
2016
Q3
$2.17M Buy
47,057
+5,000
+12% +$261K 0.06% 276
2016
Q2
$2.11M Sell
42,057
-1,649
-4% -$87.8K 0.06% 279
2016
Q1
$2.34M Hold
43,706
0.06% 285
2015
Q4
$2.87M Hold
43,706
0.07% 273
2015
Q3
$2.47M Buy
43,706
+36,355
+495% +$2.36M 0.06% 283
2015
Q2
$434K Sell
7,351
-500
-6% -$30.8K 0.01% 439
2015
Q1
$489K Hold
7,851
0.01% 430
2014
Q4
$452K Hold
7,851
0.01% 435
2014
Q3
$422K Sell
7,851
-1,050
-12% -$55.6K 0.01% 447
2014
Q2
$467K Buy
8,901
+225
+3% +$11.5K 0.01% 445
2014
Q1
$458K Sell
8,676
-1,030
-11% -$47.6K 0.01% 450
2013
Q4
$389K Sell
9,706
-767
-7% -$30.2K 0.01% 478
2013
Q3
$396K Sell
10,473
-834
-7% -$32.5K 0.01% 470
2013
Q2
$443K Buy
+11,307
New +$440K 0.01% 415

Other funds holding TEVA